BACKGROUND
CD5-positive (CD5+) diffuse large B-cell lymphoma (DLBCL) comprises ∼10% of DLBCLs, and it is associated with poor prognosis. The clinicopathologic characteristics and prognosis of CD5-negative (CD5-) DLBCL and CD5+ DLBCL were compared.
PATIENTS AND METHODS
The subjects were 607 DLBCL patients in whom cell surface markers could be analyzed, among 930 consecutive patients registered...
